Skip to content

Clinical trials

Phase 3 Non-alcoholic Fatty Liver Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Phase: Phase 3 Clear all

72 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20053
20072
20081
20092
20101
20114
20121
20131
20145
20152
20162
20175
20181
20196
20203
20215
20224
20236
20245
20256
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Recruiting11
Unknown status10
Terminated7
Active, not recruiting6
Withdrawn4
Not yet recruiting3
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
Bambino Gesù Hospital and Research Institute3
Madrigal Pharmaceuticals, Inc.3
Tanta University3
89bio, Inc.2
Akero Therapeutics, Inc2
Catalysis SL2
Gilead Sciences2
Intercept Pharmaceuticals2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease72
Fatty Liver20
Fibrosis13
Obesity7
Liver Diseases6
Liver Cirrhosis5
Diabetes Mellitus4
Diabetes Mellitus, Type 23
Hyperlipidemias3
Digestive System Diseases2

Trials

Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.